Ignite Creation Date:
2024-05-06 @ 12:35 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03790111
Status:
TERMINATED
Last Update Posted:
2023-04-19
First Post:
2018-12-25
Brief Title:
A Safety and Efficacy Study of XERMELO First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer
Sponsor:
TerSera Therapeutics LLC
Organization:
TerSera Therapeutics LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-25
First Submit QC Date:
December 27 2018
Study First Post Date:
2018-12-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-04-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-17
Last Update Post Date:
2023-04-19
Last Update Post Date Type:
ACTUAL